Literature DB >> 31446573

Eye Movements in Neuropsychological Tasks.

Timothy L Hodgson1, Gemma Ezard2, Frouke Hermens3.   

Abstract

This chapter reviews how recording and analysis of eye movements have been applied to understanding cognitive functioning in patients with neurological disease. Measures derived from the performance of instructed eye movement tests such as the anti-saccade and memory-guided saccade tasks have been shown to be associated with cognitive test performance and the early stages of neurodegenerative disorders including Alzheimer's and Parkinson's disease. Other researchers have taken an ecological approach and recorded the uninstructed pattern of saccades made by patients during performance of established neuropsychological tasks. Studies that have analysed the eye movement strategies used in a number of widely used tests are reviewed, including the Corsi blocks, Tower of London, 'CANTAB' Spatial Working Memory and Brixton Spatial Anticipation test. The findings illustrate that eye movements are not purely in the service of vision, but support visuospatial working memory and forward action planning. Eye movement tests and measures also have potential for application in the assessment and diagnosis of neurological disease and cognitive impairment. Establishing large-scale normative data sets in healthy older adults and use of machine learning multivariate classifier algorithms may be key to further developing eye tracking applications in neuropsychological assessment.

Entities:  

Keywords:  Cognitive planning; Dementia; Executive function; Frontal lobe; Oculomotor; Saccades

Mesh:

Year:  2019        PMID: 31446573     DOI: 10.1007/7854_2019_98

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  1 in total

1.  Emphasizing speed or accuracy in an eye-tracking version of the Trail-Making-Test: Towards experimental diagnostics for decomposing executive functions.

Authors:  Lukas Recker; Rebecca M Foerster; Werner X Schneider; Christian H Poth
Journal:  PLoS One       Date:  2022-09-12       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.